Trump achieves historic drug price deal with AstraZeneca, marking a significant victory for U.S. healthcare.
The Second Big Win in Two Weeks
On Friday, President Donald Trump scored another major victory in his quest to meet his campaign promise to make prescription drugs affordable for Americans.The Tariff Hammer Works
It’s a simple strategy: cooperate or face tariffs. The White House floated 100 percent penalties on imported brand-name drugs, including insulin and cancer therapies, if negotiations failed.
Both Big Pharma companies capitulated rather than risk disruption in the market or an unfavorable public confrontation over a popular policy.
For a long time, President Trump tied healthcare reform to trade fairness, arguing that Americans shouldn’t continue subsidizing cheaper drug prices for foreign governments imposing price caps. The deal with AstraZeneca has evolved from a talking point to a policy instrument.What It Means for Patients
Most likely, the largest short-term benefits will accrue to state budgets and uninsured Americans who will purchase drugs directly through the TrumpRX platform, once it’s ready.
